Skip to main content

Advertisement

Log in

Growth hormone deficiency in salt-losing congenital adrenal hyperplasia

  • Research Letter
  • Published:
European Journal of Pediatrics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Quintos JB, Vogiatzi MG, Harbison MD, New MI (2001) Growth hormone therapy alone or in combination with gonadotropin-releasing hormone analog therapy to improve the height deficit in children with congenital adrenal hyperplasia. J Clin Endocrinol Metab 86: 1511–1517

    CAS  PubMed  Google Scholar 

  2. Sheehan HL, Murdoch R (1939) Post-partum necrosis of anterior pituitary. Lancet 8: 819–820

    Google Scholar 

  3. White PC, Speiser PW (2000) Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr Rev 21: 245–291

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Richard Stanhope.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tirendi, A., Traggiai, C., Conway, G.S. et al. Growth hormone deficiency in salt-losing congenital adrenal hyperplasia. Eur J Pediatr 161, 556–558 (2002). https://doi.org/10.1007/s00431-002-0984-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00431-002-0984-y

Keywords

Navigation